Skip to main content

Peer Review reports

From: A feasibility and safety study of afamelanotide in acute stroke patients – an open label, proof of concept, phase iia clinical trial

Original Submission
6 Dec 2022 Submitted Original manuscript
Resubmission - Version 2
Submitted Manuscript version 2
Resubmission - Version 3
Submitted Manuscript version 3
27 Jan 2023 Reviewed Reviewer Report
12 May 2023 Reviewed Reviewer Report
24 Jun 2023 Author responded Author comments - Geoffrey Cloud
Resubmission - Version 4
24 Jun 2023 Submitted Manuscript version 4
24 Jun 2023 Author responded Author comments - Geoffrey Cloud
Resubmission - Version 5
24 Jun 2023 Submitted Manuscript version 5
8 Jul 2023 Reviewed Reviewer Report
Resubmission - Version 6
Submitted Manuscript version 6
Publishing
19 Jul 2023 Editorially accepted
26 Jul 2023 Article published 10.1186/s12883-023-03338-9

You can find further information about peer review here.

Back to article page